| Year |
Citation |
Score |
| 2020 |
Bathurst L, Liao L, Crozier C, Bayani J, Bartlett J, Spears M. Abstract PD2-10: Predicting sensitivity to CDK4/6 inhibition in ER+/HER2- breast cancer cell lines Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Pd2-10 |
0.359 |
|
| 2020 |
Jerzak KJ, Desautels DN, Blanchette PS, Bayani J, Nofech-Mozes S, Yaffe MJ, Pond G, Pritchard KI, Bartlett JM. Abstract P4-10-29: Identifying novel molecular markers of response to trastuzumab in metastatic breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-10-29 |
0.369 |
|
| 2020 |
Bayani J, Poncet C, Crozier C, Trinh QM, Hopkins M, Uwimana AL, Piper T, Cunningham C, Sobol M, Aebi S, Benstead K, Bogler O, Lago LD, Hilbers F, Hedenfalk I, et al. Abstract P4-10-03: The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-10-03 |
0.394 |
|
| 2020 |
Bayani J, Trinh QM, Quintayo MA, Crozier C, Lungu I, Dion D, Felipe-Lima J, Pruneri G, Bergh J, Warnberg F, Viale G, Stein LD, Bartlett JM. Abstract P3-08-22: The mutational landscape of cancer driver genes in matched primary ductal carcinomain situand recurrent ductal carcinomain situor recurrent invasive cancers Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P3-08-22 |
0.373 |
|
| 2020 |
Laible M, Aulmann S, Etzrodt A, Schmidt M, Crozier C, Wirtz R, Bayani J, Sahin U, Bartlett JM. Abstract P3-07-08: Comparison of MammaTyper® RT-qPCR based subtyping with simulated breast cancer prognostic signatures Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-07-08 |
0.34 |
|
| 2019 |
Bayani J, Poncet C, Yao C, Crozier C, Anouk N, Piper T, Cunningham C, Sobol M, Aebi S, Benstead K, Bogler O, Lago LD, Fraser J, Hilbers F, Hedenfalk I, et al. Abstract P6-19-01: Evaluation of multiple transcriptomic gene risk signatures in male breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P6-19-01 |
0.362 |
|
| 2019 |
Bathurst L, Liao L, Crozier C, Lyttle N, Marcellus R, Bayani J, Al-awar R, Bartlett J, Spears M. Abstract P5-04-24: Molecular stratification of ER+/HER2- breast cancer cell lines to predict sensitivity to targeted agents Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P5-04-24 |
0.345 |
|
| 2018 |
Rimm DL, Leung SCY, McShane LM, Bai Y, Bane AL, Bartlett JMS, Bayani J, Chang MC, Dean M, Denkert C, Enwere EK, Galderisi C, Gholap A, Hugh JC, Jadhav A, et al. An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 30143750 DOI: 10.1038/S41379-018-0109-4 |
0.323 |
|
| 2018 |
Lee M, Tayyari F, Pinnaduwage D, Bayani J, Bartlett JMS, Mulligan AM, Bull SB, Andrulis IL. Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival. Bmc Cancer. 18: 750. PMID 30029633 DOI: 10.1186/S12885-018-4653-6 |
0.365 |
|
| 2018 |
Roseweir AK, Bennett L, Dickson A, Cheng K, Quintayo MA, Bayani J, McMillan DC, Horgan PG, van de Velde CJH, Seynaeve C, Hasenburg A, Kieback DG, Markopoulos C, Dirix LY, Rea DW, et al. Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial. Journal of the National Cancer Institute. 110: 616-627. PMID 29917140 DOI: 10.1093/Jnci/Djx255 |
0.305 |
|
| 2018 |
Bayani J, Kornaga E, Crozier C, Jang G, Kalatskaya I, Trinh Q, Yao C, Livingstone J, Hasenburg A, Kieback D, Markopoulos C, Dirix L, Boutros P, Spears M, Stein L, et al. Abstract PD4-11: Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd4-11 |
0.39 |
|
| 2018 |
Spears M, Kornaga E, Lyttle N, Liao L, Bayani J, Quintayo M, Yao C, D'Costa A, Boutros P, Twelves C, Pritchard K, Levine M, Nielsen T, Shepherd L, Bartlett J. Abstract P2-10-01: Validation that a histone gene signature predicts anthracycline response in early breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P2-10-01 |
0.394 |
|
| 2018 |
Bayani J, Crozier C, Quintayo M, Amemiya Y, Zhang X, Larivière M, Sadis S, Smith J, Hasenburg A, Kieback D, Markopoulos C, Dirix L, Yaffe M, Seth A, Feilotter H, et al. Abstract P2-09-17: Evaluation of the oncomine comprehensive assay for the identification of actionable mutations for therapeutic stratification from the TEAM pathology cohort Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P2-09-17 |
0.411 |
|
| 2018 |
Bartlett J, Thomas J, Mallon E, Piper T, Bayani J, Hasenburg A, Kieback D, Markopoulos C, Dirix L, Seynaeve C, Velde Cvd, Rea D. Abstract P1-06-04: Simplified histological grading of breast carcinoma – potential for improved concordance and consistency in breast cancer grading? Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-06-04 |
0.33 |
|
| 2017 |
Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, et al. Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29092024 DOI: 10.1093/Annonc/Mdx651 |
0.321 |
|
| 2017 |
Bayani J, Kornaga E, Crozier C, Jang GH, Kalatskaya I, Trinh QM, Yao CQ, Livingstone J, Hasenburg A, Kieback DG, Markopoulos C, Dirix L, Boutros PC, Spears M, Stein LD, et al. Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers. Journal of Clinical Oncology. 35: 524-524. DOI: 10.1200/Jco.2017.35.15_Suppl.524 |
0.38 |
|
| 2017 |
Bartlett J, Kalatskaya I, Yousif F, Bayani J, Trinh QM, Heisler L, Timms L, Lee S, Buchner N, Milacic M, Rothfels K, Crozier C, Drake C, Hasenburg A, Kieback DG, et al. Targeted sequencing in a phase III trial of luminal breast cancer: Identification of novel targets. Journal of Clinical Oncology. 35: 505-505. DOI: 10.1200/Jco.2017.35.15_Suppl.505 |
0.411 |
|
| 2017 |
Bayani J, Crozier C, Zhang N, Amemiya Y, Quintayo M, Yan F, Dion D, Mccormack S, Yaffe M, Seth A, Feilotter H, Bartlett J. Abstract P1-05-27: Evaluation of the Oncomine focus and comprehensive assays for therapeutic stratification in early hormone receptor positive breast cancers Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-05-27 |
0.454 |
|
| 2017 |
Rimm D, McShane L, Leung S, Bai Y, Bane A, Bartlett J, Bayani J, Chang M, Dean M, Denkert C, Enwere E, Galderisi C, Gholap A, Hugh J, Jadhav A, et al. Abstract P1-03-01: An international multicenter study to evaluate reproducibility of automated scoring methods for assessment of Ki67 in breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-03-01 |
0.337 |
|
| 2016 |
Lima JF, Nofech-Mozes S, Bayani J, Bartlett JMS. EMT in Breast Carcinoma-A Review. Journal of Clinical Medicine. 5: 65. PMID 27429011 DOI: 10.3390/Jcm5070065 |
0.334 |
|
| 2016 |
Bartlett J, Ahmed I, Regan M, Sestak I, Mallon E, Dell'Orto P, Thürlimann B, Seynaeve C, Putter H, Brookes C, Forbes J, Colleoni M, Bayani J, Velde Cvd, Viale G, et al. Abstract S4-06: HER2 status as predictive marker for AI vs Tam benefit: A TRANS-AIOG meta-analysis of 12129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2 Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-S4-06 |
0.348 |
|
| 2016 |
Bayani J, Yao C, Quintayo M, Haider S, Brookes C, Yan F, Velde Cvd, Hasenburg A, Kieback D, Markopoulos C, Dirix L, Seynaeve C, Boutros P, Rea D, Bartlett J. Abstract P2-08-29: Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trial Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-08-29 |
0.356 |
|
| 2016 |
Lima JF, Yao C, Yan F, Dion D, Quintayo M, Lungu I, Nofech-Mozes S, Pruneri G, Viale G, Boutros P, Bartlett J, Bayani J. Abstract P1-05-01: The epithelial to mesenchymal transition: Identifying a signature of recurrence in ductal carcinoma in situ Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P1-05-01 |
0.396 |
|
| 2015 |
Meyer M, Reimand J, Lan X, Head R, Zhu X, Kushida M, Bayani J, Pressey JC, Lionel AC, Clarke ID, Cusimano M, Squire JA, Scherer SW, Bernstein M, Woodin MA, et al. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity. Proceedings of the National Academy of Sciences of the United States of America. 112: 851-6. PMID 25561528 DOI: 10.1073/pnas.1320611111 |
0.359 |
|
| 2015 |
Cardoso F, Bartlett J, Slaets L, Deurzen Cv, Leewen-Stok Ev, Porter P, Linderholm B, Hedenfalk I, Schroder C, Martens J, Bayani J, Asperen Cv, Murray M, Hudis C, Middleton L, et al. Abstract S6-05: Characterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-S6-05 |
0.344 |
|
| 2015 |
Hall PS, Smith AF, Vargas-Palacios A, Stein RC, Bartlett J, Bayani J, Marshall A, Dunn JA, Campbell AF, Cunningham C, Rooshenas L, Sobol M, Morgan A, Poole C, Pinder SE, et al. Abstract P6-08-11: UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-08-11 |
0.329 |
|
| 2015 |
Bartlett JM, Stein RC, Bayani J, Marshall A, Dunn JA, Campbell AF, Cunningham C, Sobol M, Hall P, Rooshenas L, Morgan A, Poole C, Pinder SE, Cameron DA, Stallard N, et al. Abstract P4-11-07: Comparison of multiparameter tests in the UK OPTIMA-Prelim trial Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-11-07 |
0.339 |
|
| 2015 |
Bartlett JM, Brookes CL, Yan FJ, Quintayo MA, Bayani J, Starczynski J, Velde CJvd, Hasenburg A, Kieback DG, Markopoulos C, Dirix L, Seynaeve C, Rea DW. Abstract P4-11-05: Does androgen receptor (AR) expression impact on residual risk? A TEAM pathology study Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-11-05 |
0.366 |
|
| 2015 |
Morden J, Bliss J, Bayani J, Laing R, Agrawal R, Thomas J, Goodman A, Loo V, Clark P, Canney P, Barrett-Lee P, Bartlett J, Cameron D. Abstract P4-11-04: Intrinsic subtypes and BCL2 as predictive and prognostic biomarkers in the TACT2 trial (CRUK/05/019) Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-11-04 |
0.357 |
|
| 2015 |
Bayani J, Morden J, Skaria S, Bliss P, Grieve R, Harnett A, Bradley C, Ritchie D, Barrett-Lee P, Canney P, Cameron D, Bliss J, Bartlett J. Abstract P4-11-03: Androgen receptor expression is an independent marker of lower residual risk in the TACT2 trial (CRUK/05/019) Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-11-03 |
0.371 |
|
| 2015 |
Bayani J, Quintayo MA, Yao CQ, Haider S, Brookes C, Boutros PC, Bartlett JM, Rea DW. Abstract P2-05-12: Signatures of endocrine resistance in the tamoxifen and exemestane adjuvant multinational trial (TEAM)-UK cohort Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P2-05-12 |
0.377 |
|
| 2015 |
Yao CQ, Crozier C, Quintayo MA, Bayani J, Spears M, Livingstone J, Jung E, Fung C, Sabine V, Boutros PC, Bartlett JM. Abstract P2-03-17: Assessing reproducibility of copy number arrays to assist breast cancer biomarker discovery Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P2-03-17 |
0.43 |
|
| 2013 |
Schmitt M, Magdolen V, Yang F, Kiechle M, Bayani J, Yousef GM, Scorilas A, Diamandis EP, Dorn J. Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies. Radiology and Oncology. 47: 319-29. PMID 24294176 DOI: 10.2478/Raon-2013-0053 |
0.621 |
|
| 2013 |
Dorn J, Bayani J, Yousef GM, Yang F, Magdolen V, Kiechle M, Diamandis EP, Schmitt M. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Thrombosis and Haemostasis. 110: 408-22. PMID 23765253 DOI: 10.1160/Th13-03-0206 |
0.624 |
|
| 2013 |
Oros KK, Arcand SL, Bayani J, Squire JA, Mes-Masson AM, Tonin PN, Greenwood CM. Analysis of genomic abnormalities in tumors: a review of available methods for Illumina two-color SNP genotyping and evaluation of performance. Cancer Genetics. 206: 103-15. PMID 23623180 DOI: 10.1016/J.Cancergen.2013.03.001 |
0.385 |
|
| 2013 |
Bayani J, Kuzmanov U, Saraon P, Fung WA, Soosaipillai A, Squire JA, Diamandis EP. Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression. Clinical Chemistry. 59: 296-305. PMID 23136250 DOI: 10.1373/Clinchem.2012.193060 |
0.698 |
|
| 2012 |
Girgis AH, Iakovlev VV, Beheshti B, Bayani J, Squire JA, Bui A, Mankaruos M, Youssef Y, Khalil B, Khella H, Pasic M, Yousef GM. Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma. Cancer Research. 72: 5273-84. PMID 22926558 DOI: 10.1158/0008-5472.Can-12-0656 |
0.554 |
|
| 2012 |
Seiz L, Dorn J, Kotzsch M, Walch A, Grebenchtchikov NI, Gkazepis A, Schmalfeldt B, Kiechle M, Bayani J, Diamandis EP, Langer R, Sweep FCGJ, Schmitt M, Magdolen V. Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients Biological Chemistry. 393: 391-401. PMID 22505521 DOI: 10.1515/Hsz-2011-0264 |
0.528 |
|
| 2012 |
Bayani J, Diamandis EP. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6) Clinical Chemistry and Laboratory Medicine. 50: 211-233. PMID 22047144 DOI: 10.1515/Cclm.2011.750 |
0.522 |
|
| 2011 |
Pandita A, Bayani J, Paderova J, Marrano P, Graham C, Barrett M, Prasad M, Zielenska M, Squire JA. Integrated cytogenetic and high-resolution array CGH analysis of genomic alterations associated with MYCN amplification. Cytogenetic and Genome Research. 134: 27-39. PMID 21508638 DOI: 10.1159/000324698 |
0.43 |
|
| 2011 |
Bayani J, Marrano P, Graham C, Zheng Y, Li L, Katsaros D, Lassus H, Butzow R, Squire JA, Diamandis EP. Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas. Molecular Oncology. 5: 48-60. PMID 20800559 DOI: 10.1016/J.Molonc.2010.08.002 |
0.572 |
|
| 2011 |
Bayani J, Kuzmanov U, Smith C, Batruch I, Presvelos J, Graham C, Squire JA, Diamandis EP. Abstract 1168: Integrated genomic, microRNA (miRNA) and proteomic profiling by stable isotope labeling with amino acids in cell culture (SILAC) of ovarian carcinoma for biomarker discovery Cancer Research. 71: 1168-1168. DOI: 10.1158/1538-7445.Am2011-1168 |
0.488 |
|
| 2010 |
Lin D, Bayani J, Wang Y, Sadar MD, Yoshimoto M, Gout PW, Squire JA, Wang Y. Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor. The Prostate. 70: 1636-44. PMID 20564316 DOI: 10.1002/Pros.21199 |
0.357 |
|
| 2010 |
Bayani J, Kuzmanov U, Batruch I, Cho C, Smith C, Marrano P, Graham C, Butzow R, Katsaros D, Lin L, Zheng Y, Squire JA, Diamandis EP. Abstract 3037: Integrated Genomic, MicroRNA (miRNA) and Proteomic Profiling of Ovarian Carcinoma for Biomarker Discovery Cancer Research. 70: 3037-3037. DOI: 10.1158/1538-7445.Am10-3037 |
0.492 |
|
| 2009 |
Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M, Squire JA, Smith A, Dirks P. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell. 4: 568-80. PMID 19497285 DOI: 10.1016/J.Stem.2009.03.014 |
0.323 |
|
| 2008 |
Bayani J, Paliouras M, Planque C, Shan SJ, Graham C, Squire JA, Diamandis EP. Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer. Molecular Oncology. 2: 250-60. PMID 19383346 DOI: 10.1016/J.Molonc.2008.07.001 |
0.572 |
|
| 2008 |
Selvarajah S, Yoshimoto M, Ludkovski O, Park PC, Bayani J, Thorner P, Maire G, Squire JA, Zielenska M. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH. Cytogenetic and Genome Research. 122: 5-15. PMID 18931480 DOI: 10.1159/000151310 |
0.382 |
|
| 2008 |
Bayani J, Paderova J, Murphy J, Rosen B, Zielenska M, Squire JA. Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer. Neoplasia (New York, N.Y.). 10: 1057-65. PMID 18813350 DOI: 10.1593/Neo.08584 |
0.425 |
|
| 2008 |
Maire G, Brown CW, Bayani J, Pereira C, Gravel DH, Bell JC, Zielenska M, Squire JA. Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review. Cancer Genetics and Cytogenetics. 181: 81-92. PMID 18295659 DOI: 10.1016/J.Cancergencyto.2007.11.002 |
0.441 |
|
| 2007 |
Selvarajah S, Yoshimoto M, Maire G, Paderova J, Bayani J, Squire JA, Zielenska M. Identification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridization. Cancer Genetics and Cytogenetics. 179: 52-61. PMID 17981215 DOI: 10.1016/J.Cancergencyto.2007.08.003 |
0.392 |
|
| 2007 |
Al-Romaih K, Somers GR, Bayani J, Hughes S, Prasad M, Cutz JC, Xue H, Zielenska M, Wang Y, Squire JA. Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation. Cancer Cell International. 7: 14. PMID 17845729 DOI: 10.1186/1475-2867-7-14 |
0.336 |
|
| 2007 |
Ghazani AA, Arneson N, Warren K, Pintilie M, Bayani J, Squire JA, Done SJ. Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization. Neoplasia (New York, N.Y.). 9: 511-20. PMID 17603634 DOI: 10.1593/Neo.07301 |
0.47 |
|
| 2007 |
Yoshimoto M, Ludkovski O, Bayani J, Graham C, Zielenska M, Squire JA. Microdeletion and concurrent translocation associated with a complex TMPRSS2:ERG prostate cancer gene fusion. Genes, Chromosomes & Cancer. 46: 861-3. PMID 17584912 DOI: 10.1002/Gcc.20470 |
0.338 |
|
| 2007 |
Bayani J, Squire JA. Application and interpretation of FISH in biomarker studies. Cancer Letters. 249: 97-109. PMID 17287077 DOI: 10.1016/J.Canlet.2006.12.030 |
0.366 |
|
| 2007 |
Vukovic B, Beheshti B, Park P, Lim G, Bayani J, Zielenska M, Squire JA. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer. Cytogenetic and Genome Research. 116: 1-11. PMID 17268171 DOI: 10.1159/000097411 |
0.438 |
|
| 2007 |
Bayani J, Selvarajah S, Maire G, Vukovic B, Al-Romaih K, Zielenska M, Squire JA. Genomic mechanisms and measurement of structural and numerical instability in cancer cells. Seminars in Cancer Biology. 17: 5-18. PMID 17126026 DOI: 10.1016/J.Semcancer.2006.10.006 |
0.399 |
|
| 2007 |
Bowles E, Corson TW, Bayani J, Squire JA, Wong N, Lai PB, Gallie BL. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes, Chromosomes & Cancer. 46: 118-29. PMID 17099872 DOI: 10.1002/Gcc.20383 |
0.44 |
|
| 2006 |
Yoshimoto M, Bayani J, Nuin PAS, Silva NS, Cavalheiro S, Stavale JN, Andrade JAD, Zielenska M, Squire JA, de Toledo SRC. Metaphase and array comparative genomic hybridization: unique copy number changes and gene amplification of medulloblastomas in South America Cancer Genetics and Cytogenetics. 170: 40-47. PMID 16965953 DOI: 10.1016/J.Cancergencyto.2006.05.009 |
0.44 |
|
| 2006 |
Yoshimoto M, Cutz JC, Nuin PAS, Joshua AM, Bayani J, Evans AJ, Zielenska M, Squire JA. Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias Cancer Genetics and Cytogenetics. 169: 128-137. PMID 16938570 DOI: 10.1016/J.Cancergencyto.2006.04.003 |
0.408 |
|
| 2006 |
Selvarajah S, Yoshimoto M, Park PC, Maire G, Paderova J, Bayani J, Lim G, Al-Romaih K, Squire JA, Zielenska M. The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma Chromosoma. 115: 459-467. PMID 16897100 DOI: 10.1007/S00412-006-0074-4 |
0.315 |
|
| 2006 |
Yoshimoto M, Joshua AM, Chilton-MacNeill S, Bayani J, Selvarajah S, Evans AJ, Zielenska M, Squire JA. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement Neoplasia. 8: 465-469. PMID 16820092 DOI: 10.1593/Neo.06283 |
0.433 |
|
| 2006 |
Cutz JC, Guan J, Bayani J, Yoshimoto M, Xue H, Sutcliffe M, English J, Flint J, LeRiche J, Yee J, Squire JA, Gout PW, Lam S, Wang YZ. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4043-54. PMID 16818704 DOI: 10.1158/1078-0432.Ccr-06-0252 |
0.396 |
|
| 2006 |
Yoshimoto M, Joshua AM, Chilton-Macneill S, Bayani J, Prasad M, Fleshner N, Finelli A, Evans A, Sweet J, Squire J, Zielenska M. Detection of novel variant TMPRSS2 /ERG fusion transcripts suggests independent genomic alterations may underlie origin of multi-centric prostate cancer Journal of Clinical Oncology. 24: 10029-10029. DOI: 10.1200/Jco.2006.24.18_Suppl.10029 |
0.349 |
|
| 2005 |
Bayani J, Squire JA. Detection of mitotic figures and components of the mitotic machinery. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 22.8. PMID 18228469 DOI: 10.1002/0471143030.Cb2208S25 |
0.364 |
|
| 2005 |
Bayani J, Squire JA. Comparative genomic hybridization. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 22.6. PMID 18228467 DOI: 10.1002/0471143030.Cb2206S25 |
0.37 |
|
| 2005 |
Bayani J, Pandita A, Squire JA. Molecular cytogenetic analysis in the study of brain tumors: findings and applications Neurosurgical Focus [Electronic Resource].. 19: E1. PMID 16398459 DOI: 10.3171/Foc.2005.19.5.2 |
0.382 |
|
| 2005 |
Wang Y, Xue H, Cutz JC, Bayani J, Mawji NR, Chen WG, Goetz LJ, Hayward SW, Sadar MD, Gilks CB, Gout PW, Squire JA, Cunha GR, Wang YZ. An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Laboratory Investigation; a Journal of Technical Methods and Pathology. 85: 1392-404. PMID 16155594 DOI: 10.1038/Labinvest.3700335 |
0.333 |
|
| 2005 |
Lim G, Karaskova J, Beheshti B, Vukovic B, Bayani J, Selvarajah S, Watson SK, Lam WL, Zielenska M, Squire JA. An integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma Genes Chromosomes and Cancer. 42: 392-403. PMID 15660435 DOI: 10.1002/Gcc.20157 |
0.438 |
|
| 2004 |
Bayani J, Squire J. Multi-color FISH techniques Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. PMID 18228456 DOI: 10.1002/0471143030.Cb2205S24 |
0.352 |
|
| 2004 |
Bayani J, Squire JA. Fluorescence in situ Hybridization (FISH). Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 22.4. PMID 18228455 DOI: 10.1002/0471143030.Cb2204S23 |
0.307 |
|
| 2004 |
Bayani J, Squire JA. Traditional banding of chromosomes for cytogenetic analysis. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 22.3. PMID 18228454 DOI: 10.1002/0471143030.Cb2203S23 |
0.305 |
|
| 2004 |
Bayani J, Squire JA. Overview of cytogenetic chromosome analysis. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 22.1. PMID 18228452 DOI: 10.1002/0471143030.Cb2201S23 |
0.366 |
|
| 2004 |
Yoshimoto M, de Toledo SR, da Silva NS, Bayani J, Bertozzi AP, Stavale JN, Cavalheiro S, Andrade JA, Zielenska M, Squire JA. Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature. Journal of Neurosurgery. 101: 85-90. PMID 16206977 DOI: 10.3171/Ped.2004.101.2.0085 |
0.393 |
|
| 2004 |
Lim G, Karaskova J, Vukovic B, Bayani J, Beheshti B, Bernardini M, Squire JA, Zielenska M. Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63 Cancer Genetics and Cytogenetics. 153: 158-164. PMID 15350306 DOI: 10.1016/J.Cancergencyto.2004.01.016 |
0.428 |
|
| 2004 |
Zielenska M, Marrano P, Thorner P, Pei J, Beheshti B, Ho M, Bayani J, Liu Y, Sun BC, Squire JA, Haod XS. High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue Cytogenetic and Genome Research. 107: 77-82. PMID 15305059 DOI: 10.1159/000079574 |
0.373 |
|
| 2004 |
Hughes S, Lim G, Beheshti B, Bayani J, Marrano P, Huang A, Squire JA. Use of whole genome amplification and comparative genomic hybridisation to detect chromosomal copy number alterations in cell line material and tumour tissue Cytogenetic and Genome Research. 105: 18-24. PMID 15218253 DOI: 10.1159/000078004 |
0.341 |
|
| 2004 |
Taylor MD, Raffel C, Bayani J, Marrano P, Mainprize TG, Squire J. Advanced cancer genetics in neurosurgical research. Neurosurgery. 53: 1168-78; discussion . PMID 14580285 DOI: 10.1227/01.Neu.0000088807.95566.9B |
0.394 |
|
| 2003 |
Squire JA, Pei J, Marrano P, Beheshti B, Bayani J, Lim G, Moldovan L, Zielenska M. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays Genes Chromosomes and Cancer. 38: 215-225. PMID 14506695 DOI: 10.1002/Gcc.10273 |
0.434 |
|
| 2003 |
Al-Romaih K, Bayani J, Vorobyova J, Karaskova J, Park PC, Zielenska M, Squire JA. Chromosomal instability in osteosarcoma and its association with centrosome abnormalities Cancer Genetics and Cytogenetics. 144: 91-99. PMID 12850370 DOI: 10.1016/S0165-4608(02)00929-9 |
0.408 |
|
| 2003 |
Nowaczyk MJM, Bayani J, Freeman V, Watts J, Squire J, Xu J. De novo 1q32q44 duplication and distal 1q trisomy syndrome American Journal of Medical Genetics Part A. 120: 229-233. PMID 12833404 DOI: 10.1002/Ajmg.A.20028 |
0.37 |
|
| 2003 |
Bayani J, Zielenska M, Pandita A, Al-Romaih K, Karaskova J, Harrison K, Bridge JA, Sorensen P, Thorner P, Squire JA. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas Genes Chromosomes and Cancer. 36: 7-16. PMID 12461745 DOI: 10.1002/Gcc.10132 |
0.414 |
|
| 2002 |
Squire JA, Bayani J, Luk C, Unwin L, Tokunaga J, MacMillan C, Irish J, Brown D, Gullane P, Kamel-Reid S. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head & Neck. 24: 874-87. PMID 12211052 DOI: 10.1002/Hed.10122 |
0.428 |
|
| 2002 |
Bayani J, Brenton JD, Macgregor PF, Beheshti B, Albert M, Nallainathan D, Karaskova J, Rosen B, Murphy J, Laframboise S, Zanke B, Squire JA. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays Cancer Research. 62: 3466-3476. PMID 12067990 |
0.358 |
|
| 2002 |
Bayani JM, Squire JA. Applications of SKY in cancer cytogenetics Cancer Investigation. 20: 373-386. PMID 12025233 DOI: 10.1081/Cnv-120001183 |
0.478 |
|
| 2001 |
Zielenska M, Bayani J, Pandita A, Toledo S, Marrano P, Andrade J, Petrilli A, Thorner P, Sorensen P, Squire JA. Comparative genomic hybridization analysis identifies gains of 1p35∼p36 and chromosome 19 in osteosarcoma Cancer Genetics and Cytogenetics. 130: 14-21. PMID 11672768 DOI: 10.1016/S0165-4608(01)00461-7 |
0.431 |
|
| 2001 |
Squire JA, Arab S, Marrano P, Bayani J, Karaskova J, Taylor M, Becker L, Rutka J, Zielenska M. Molecular cytogenetic analysis of glial tumors using spectral karyotyping and comparative genomic hybridization Molecular Diagnosis. 6: 93-108. PMID 11468694 DOI: 10.1054/Modi.2001.22745 |
0.374 |
|
| 2001 |
Zielenska M, Zhang ZM, Ng K, Marrano P, Bayani J, Ramirez OC, Sorensen P, Thorner P, Greenberg M, Squire JA. Acquisition of secondary structural chromosomal changes in pediatric ewing sarcoma is a probable prognostic factor for tumor response and clinical outcome. Cancer. 91: 2156-64. PMID 11391597 DOI: 10.1002/1097-0142(20010601)91:11<2156::Aid-Cncr1244>3.0.Co;2-I |
0.441 |
|
| 2001 |
Luk C, Tsao MS, Bayani J, Shepherd F, Squire JA. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization Cancer Genetics and Cytogenetics. 125: 87-99. PMID 11369051 DOI: 10.1016/S0165-4608(00)00363-0 |
0.39 |
|
| 2001 |
Bayani J, Squire J. Advances in the detection of chromosomal aberrations using spectral karyotyping Clinical Genetics. 59: 65-73. PMID 11260203 DOI: 10.1034/j.1399-0004.2001.590201.x |
0.316 |
|
| 2000 |
Bayani J, Zielenska M, Marrano P, Kwan Ng Y, Taylor MD, Jay V, Rutka JT, Squire JA. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. Journal of Neurosurgery. 93: 437-48. PMID 10969942 DOI: 10.3171/Jns.2000.93.3.0437 |
0.431 |
|
| 2000 |
Barnard M, Bayani J, Grant R, Teshima I, Thorner P, Squire J. Use of Multicolor Spectral Karyotyping in Genetic Analysis of Pleuropulmonary Blastoma Pediatric and Developmental Pathology. 3: 479-486. PMID 10890933 DOI: 10.1007/S100240010094 |
0.403 |
|
| 2000 |
Squire JA, Li M, Perlikowski S, Fei YL, Bayani J, Zhang ZM, Weksberg R. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome Genomics. 65: 234-242. PMID 10857747 DOI: 10.1006/Geno.2000.6155 |
0.326 |
|
| 2000 |
Safar A, Nelson M, Neff JR, Maale GE, Bayani J, Squire J, Bridge JA. Recurrent anomalies of 6q25 in chondromyxoid fibroma Human Pathology. 31: 306-311. PMID 10746672 DOI: 10.1016/S0046-8177(00)80243-9 |
0.374 |
|
| 2000 |
Barnard M, Bayani J, Grant R, Zielenska M, Squire J, Thorner P. Comparative genomic hybridization analysis of clear cell sarcoma of the kidney. Medical and Pediatric Oncology. 34: 113-116. PMID 10657872 DOI: 10.1002/(Sici)1096-911X(200002)34:2<113::Aid-Mpo8>3.0.Co;2-N |
0.414 |
|
| 2000 |
Boehm AK, Neff JR, Squire JA, Bayani J, Nelson M, Bridge JA. Cytogenetic findings in 36 osteosarcoma specimens and a review of the literature Pediatric Pathology and Molecular Medicine. 19: 359-376. DOI: 10.1080/15513810009168645 |
0.406 |
|
| 1999 |
Pandita A, Zielenska M, Thorner P, Bayani J, Godbout R, Greenberg M, Squire JA. Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia (New York, N.Y.). 1: 262-75. PMID 10935481 DOI: 10.1038/Sj.Neo.7900036 |
0.476 |
|
| 1999 |
Jay V, Squire J, Bayani J, Alkhani AM, Rutka JT, Zielenska M. Oncogene amplification in medulloblastoma: analysis of a case by comparative genomic hybridization and fluorescence in situ hybridization. Pathology. 31: 337-44. PMID 10643003 DOI: 10.1080/003130299104693 |
0.441 |
|
| 1999 |
Bayani J, Pandita A, Squire JA. Sequential G-banding, SKY and FISH provide a refined identification of translocation breakpoints and complex chromosomal rearrangements Technical Tips Online. 4: 66-69. DOI: 10.1016/S1366-2120(08)70142-9 |
0.318 |
|
| 1997 |
Pandita A, Godbout R, Zielenska M, Thorner P, Bayani J, Squire JA. Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH. Genes, Chromosomes & Cancer. 20: 243-52. PMID 9365831 DOI: 10.1002/(Sici)1098-2264(199711)20:3<243::Aid-Gcc4>3.0.Co;2-2 |
0.398 |
|
| 1997 |
Hannigan GE, Bayani J, Weksberg R, Beatty B, Pandita A, Dedhar S, Squire J. Mapping of the gene encoding the integrin-linked kinase, ILK, to human chromosome 11p15.5-p15.4. Genomics. 42: 177-9. PMID 9177792 DOI: 10.1006/Geno.1997.4719 |
0.352 |
|
| 1995 |
Bayani J, Thorner P, Zielenska M, Pandita A, Beatty B, Squire JA. Application of a Simplified Comparative Genomic Hybridization Technique to Screen for Gene Amplification in Pediatric Solid Tumors Pediatric Pathology & Laboratory Medicine. 15: 831-844. PMID 8705194 DOI: 10.3109/15513819509027020 |
0.387 |
|
| 1995 |
Beatty BG, Thorner PT, Zielenska M, Bayani J, Pandita A, Becker LE, Squire JA. Detection of gene amplification in pediatric solid tumors using a simplified comparative genomic hybridization technique Cancer Genetics and Cytogenetics. 84: 151. DOI: 10.1016/0165-4608(96)85290-3 |
0.357 |
|
| Show low-probability matches. |